Full Text View
Tabular View
Study Results
Related Studies
Effect of Licorice and Hydrochlorothiazide on Plasma Potassium
This study has been completed.
Study NCT00605202   Information provided by University of Oulu

First Received on January 17, 2008.   Last Updated on December 10, 2009   History of Changes
Results First Received: August 13, 2009  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Safety Study;   Intervention Model: Crossover Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Condition: Hypokalemia
Interventions: Drug: Hydrochlorothiazide
Dietary Supplement: Licorice

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Licorice First, Then Licorice and HCTZ Licorice 32 grams a day in the first intervention period, then licorice 32 grams a day together with Hydrochlorothiazide 25 mg once daily in the second intervention period.
Licorice and HCTZ First, Then Licorice Licorice 32 grams a day together with Hydrochlorothiazide 25 mg once daily in the first intervention period, then licorice 32 grams a day in the second intervention period.

Participant Flow for 3 periods

Period 1:   First Intervention
    Licorice First, Then Licorice and HCTZ     Licorice and HCTZ First, Then Licorice  
STARTED     5     5  
COMPLETED     5     5  
NOT COMPLETED     0     0  

Period 2:   Washout Period of 3 Weeks
    Licorice First, Then Licorice and HCTZ     Licorice and HCTZ First, Then Licorice  
STARTED     5     5  
COMPLETED     5     5  
NOT COMPLETED     0     0  

Period 3:   Second Intervention
    Licorice First, Then Licorice and HCTZ     Licorice and HCTZ First, Then Licorice  
STARTED     5     5  
COMPLETED     5     5  
NOT COMPLETED     0     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Entire Study Population No text entered.

Baseline Measures
    Entire Study Population  
Number of Participants  
[units: participants]
  10  
Age  
[units: participants]
 
<=18 years     0  
Between 18 and 65 years     10  
>=65 years     0  
Gender  
[units: participants]
 
Female     5  
Male     5  
Region of Enrollment  
[units: participants]
 
Finland     10  



  Outcome Measures

1.  Primary:   Plasma Potassium   [ Time Frame: Baseline and 2 weeks ]


  Serious Adverse Events
  Show Serious Adverse Events


  Other Adverse Events
  Show Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.  


Results Point of Contact:  
Name/Title: Janne Hukkanen
Organization: Oulu University Hospital, Department of Internal Medicine
phone: +358-8-315 6212
e-mail: janne.hukkanen@oulu.fi


Publications of Results:

Responsible Party: Professor Markku Savolainen, Oulu University Hospital
ClinicalTrials.gov Identifier: NCT00605202     History of Changes
Other Study ID Numbers: Lakritsi ja hypokalemia
Study First Received: January 17, 2008
Results First Received: August 13, 2009
Last Updated: December 10, 2009
Health Authority: Finland: Finnish Medicines Agency